BrainsWay Ltd. (TLV:BWAY)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,000.00
-2.00 (-0.10%)
Jul 31, 2025, 5:24 PM IDT

BrainsWay Company Description

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.

It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases.

The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd.
BrainsWay logo
CountryIsrael
Founded2003
IndustryMedical Devices
SectorHealthcare
Employees120
CEOHadar Levy

Contact Details

Address:
16 Hartum St
Jerusalem, 9777516
Israel
Phone972 2 582 4030
Websitebrainsway.com

Stock Details

Ticker SymbolBWAY
ExchangeTel Aviv Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberIL0011007189
SIC Code3845

Key Executives

NamePosition
Hadar LevyChief Executive Officer
Dr. David Zacut M.D.Co-Founder and Vice-Chairman
Avner HagaiFounder and Director
Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board and Director
Ido MaromChief Financial Officer
Ross MitchellVice President of Global Marketing
Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs
Michael CohenVice President of US Sales
Dr. Yiftach Roth Ph.D.Founder and Chief Scientific Officer
Dor HagaiVice President of Operations